Open Access Green as soon as Postprint is submitted to ZB.
Heterozygous de novo variants in CSNK1G1 are associated with syndromic developmental delay and autism spectrum disorder.
Clin. Genet. 98, 571-576 (2020)
The gamma-1 isoform of casein kinase 1, the protein encoded byCSNK1G1, is involved in the growth and morphogenesis of cells. This protein is expressed ubiquitously among many tissue types, including the brain, where it regulates the phosphorylation of N-methyl-D-aspartate receptors and plays a role in synaptic transmission. One prior individual with a de novo variant inCSNK1Gpresenting with severe developmental delay and early-onset epilepsy has been reported. Here we report an updated clinical history of this previously published case, as well as four additional individuals with de novo variants inCSNK1G1identified via microarray-based comparative genomic hybridization, exome, or genome sequencing. All individuals (n = 5) had developmental delay. At least three individuals had diagnoses of autism spectrum disorder. All participants were noted to have dysmorphic facial features, although the reported findings varied widely and therefore may not clearly be recognizable. None of the participants had additional major malformations. Taken together, our data suggest thatCSNK1G1may be a cause of syndromic developmental delay and possibly autism spectrum disorder.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Scientific Article
Keywords
Autism ; Developmental Delay ; Genetic Diagnosis ; Genetic Syndrome; Casein Kinase-1; Gilgamesh; Mutations; Genes
ISSN (print) / ISBN
0009-9163
e-ISSN
1399-0004
Journal
Clinical Genetics
Quellenangaben
Volume: 98,
Issue: 6,
Pages: 571-576
Publisher
Wiley
Publishing Place
111 River St, Hoboken 07030-5774, Nj Usa
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute of Human Genetics (IHG)
Grants
National Institute for Health Research (NIHR) Oxford Biomedical Research Centre